Hepatocellular Carcinoma Is Associated With an Increased Risk of Hepatitis B Virus Recurrence After Liver Transplantation (original) (raw)
Association Between Hepatitis B and Hepatocellular Carcinoma Recurrence in Patients Undergoing Liver Transplantation
Deniz Sigirli
Transplantation Proceedings, 2008
View PDFchevron_right
Presence of intrahepatic (total and ccc) HBV DNA is not predictive of HBV recurrence after liver transplantation
Munira Hussain
Liver Transplantation, 2007
View PDFchevron_right
Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation
Francisco Durazo
Liver Transplantation, 2009
View PDFchevron_right
Risk of HBV reinfection after liver transplantation in HBsAg-positive cirrhosis. Primary hepatocellular carcinoma is not a predictor for HBV recurrence. The European Cooperative Study Group on Liver Cancer and Transplantation
Ferruccio Bonino
Liver, 1996
View PDFchevron_right
Clinical outcomes of liver transplantation for HBV-related hepatocellular carcinoma: data from the NIH HBV OLT study
Steven-huy Han
Clinical Transplantation, 2010
View PDFchevron_right
Serum hepatitis B virus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxis
Kazuhide Yamamoto, Fusao Ikeda, Y. Iwasaki, Ryuichi Yoshida, Satoshi Hirohata
Hepatology International, 2011
View PDFchevron_right
Evaluation of Impact of Serial Hepatitis B Virus DNA Levels on Development of Hepatocellular Carcinoma
Vincent Wong
Journal of Clinical Microbiology, 2009
View PDFchevron_right
Significance of HBV DNA in the Hepatic Parenchyma from Patients with Non-B, Non-C Hepatocellular Carcinoma
Hidetoshi Ota
World Journal of Surgery, 2006
View PDFchevron_right
Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis
Man-fung Yuen
Clinical Gastroenterology and Hepatology, 2019
View PDFchevron_right
HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis
Valérie Delvart, Cyrille Feray
Hepatology, 2003
View PDFchevron_right
Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma
Chien-wei Su, Jaw-ching Wu
Journal of Hepatology, 2009
View PDFchevron_right
High Viremia, Prolonged Lamivudine Therapy and Recurrent Hepatocellular Carcinoma Predict Posttransplant Hepatitis B Recurrence†
Hahn Lee
American Journal of Transplantation, 2010
View PDFchevron_right
The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy
Hao-jan Lei, Chien-wei Su
PLoS ONE, 2013
View PDFchevron_right
Reduced HBV cccDNA and HBsAg in HBV-associated hepatocellular carcinoma tissues
Ravat Panvichian
Medical Oncology, 2018
View PDFchevron_right
INFLUENCE OF ANTIVIRAL THERAPY IN THE NATURAL HISTORY OF HEPATITIS B VIRUS RECURRENCE AFTER LIVER TRANSPLANTATION: RETROSPECTIVE STUDY OF 14 CASES
Javier de Haro
Transplantation, 1999
View PDFchevron_right
Virologic and Biochemical Changes and Prognosis after Liver Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma
Shigekazu Takemura
Digestive Surgery, 2001
View PDFchevron_right
Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma
Man-fung Yuen
Hepatology, 2011
View PDFchevron_right
Does pre-liver transplant HBV DNA level affect HBV recurrence or survival in liver transplant recipients receiving HBIg and nucleos(t)ide analogues?
Jaime Guardia
Annals of hepatology
View PDFchevron_right
Persistent Risk for HBV Associated Hepatocellular Carcinoma in spite of Sustained and Successful Viral Suppression: The Need for Drugs for HBV Cure
Hie-won Hann
Cancer Studies
View PDFchevron_right
Hepatitis B virus related hepatocellular carcinoma: chronicity of infection - the opening to different pathways of malignant transformation?
Cem Kalayci
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1990
View PDFchevron_right
Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Long After Achieving Hbsag Seroconversion: A Need for an Improved Hepatitis B Virus DNA Assay
Hie-won Hann
Clinical microbiology, 2012
View PDFchevron_right
Case Report Open Access Clinical Microbiology: Open Access Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Long After Achieving Hbsag Seroconversion: A Need for an Improved Hepatitis B Virus DNA Assay
Hie-won Hann
2016
View PDFchevron_right
Influence of serum HBV DNA load on recurrence of hepatocellular carcinoma after treatment with percutaneous radiofrequency ablation
Ryosuke Tateishi
2011
View PDFchevron_right
Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection
G. Squadrito, Irene Cacciola
Hepatology, 2000
View PDFchevron_right
Real-time quantitation of hepatitis B virus (HBV) DNA in tumorous and surrounding tissue from patients with hepatocellular carcinoma
Elisabetta Cariani
Journal of Medical Virology, 2002
View PDFchevron_right
Total and covalently closed circular DNA detection in liver tissue of long-term survivors transplanted for HBV-related cirrhosis
Tania Guenci, Marco Ciotti
Digestive and Liver Disease, 2010
View PDFchevron_right
Effects of Genomic Changes in Hepatitis B Virus on Postoperative Recurrence and Survival in Patients with Hepatocellular Carcinoma
Priya Mathews
Annals of Surgical Oncology, 2013
View PDFchevron_right
Prediction of Hepatocellular Carcinoma Recurrence in Patients With Low Hepatitis B Virus DNA Levels and High Preoperative Hepatitis B Surface Antigen Levels
Juinn Kam
JAMA surgery, 2014
View PDFchevron_right